The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Veterinary Biologics Market Change Between 2026 And 2030?
The veterinary biologics market has experienced robust expansion over recent years. It is projected to increase from $13.61 billion in 2025 to $14.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. This historical growth can be largely attributed to the increasing prevalence of livestock diseases, a surge in the companion animal population, significant advancements in vaccine development, enhanced government funding for veterinary research, and the continued expansion of veterinary healthcare infrastructure.
The veterinary biologics market is projected to experience substantial expansion in the coming years. This market is forecast to reach $20.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. This anticipated growth is driven by factors such as technological innovations in biologics, the increasing use of precision medicine for animals, a global increase in pet ownership, heightened awareness of zoonotic diseases, and the expanding veterinary diagnostics market. Key trends expected during this period involve a greater emphasis on preventive animal healthcare, the wider adoption of rapid diagnostic solutions, the expansion of biologics for companion animals, the incorporation of immunomodulators into veterinary therapies, and an increasing need for solutions to manage livestock diseases.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp
Which Major Factors Are Contributing To The Development Of The Veterinary Biologics Market?
The increasing adoption of pets is expected to propel the growth of the veterinary biologics market going forward. Pet adoption refers to the process of taking responsibility for a domesticated animal, often from a shelter, or rescue organization, to provide the animal with a permanent and caring home. Adoption of pets is rising due to increased awareness of animal welfare, as more people recognize the benefits of adopting rescued animals and choose adoption over purchasing pets. Veterinary biologics prevent the impact of various infectious diseases in pets, provide immunity, and control of zoonotic diseases, improve lifespan and quality of life, reduce veterinary healthcare costs, enhance reproductive health in pets, and offer more targeted and customized treatment options. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, ninety-four (94) million U.S. households own at least one pet, compared to eighty-two (82) million in 2023. Therefore, the increasing adoption of pets is driving the growth of the veterinary biologics market.
What Segment Types Are Included In The Veterinary Biologics Market Analysis?
The veterinary biologics market covered in this report is segmented –
1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products
2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Disease Types
3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels
4) By Application: Production Animal, Companion Animal
Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines
2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits
3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants
4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums
5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids
Which Trends Are Guiding The Development Of The Veterinary Biologics Market?
Major companies operating in the veterinary biologics market are focusing on developing novel biologics such as vaccines to enhance animal health and disease prevention. A vaccine is a substance that stimulates the immune system to recognize and fight specific pathogens. It helps prevent infectious diseases by providing acquired immunity. For instance, in August 2024, Merck Animal Health, a US-based global animal health company, launched an experimental autogenous vaccine targeting avian metapneumovirus (aMPV) type B, receiving approval from the U.S. Department of Agriculture (USDA) for manufacturing and sale. Developed in collaboration with Cambridge Technologies, this vaccine aims to combat the severe respiratory issues caused by aMPV type B in poultry, which have led to significant economic losses since late 2023. Produced at a state-of-the-art facility in Minnesota, the vaccine features an oil and water emulsion formulation designed to minimize post-vaccination tissue reactions, addressing a critical gap in the market as no commercially licensed vaccines were previously available.
Who Are The Major Companies Operating In The Veterinary Biologics Market?
North America was the largest region in the veterinary biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access The Complete Veterinary Biologics Market Report:
https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report
Which Regional Market Leads The Veterinary Biologics Market?
North America was the largest region in the veterinary biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Veterinary Biologics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model